22 min listen
Here's How the New Weight Loss Drugs Could Change Everything
FromOdd Lots
ratings:
Length:
55 minutes
Released:
Aug 17, 2023
Format:
Podcast episode
Description
There's a new class of weight-loss drugs in town. GLP-1 medications including Ozempic, Wegovy and Mounjaro were created to treat diabetes but have since been found to suppress appetites and induce substantial weight loss. It's a big deal for the companies which make them, with shares of Novo Nordisk and Eli Lilly all soaring in recent weeks. But the drugs could end up having a much broader economic impact too. On this episode, we speak with James van Geelen of Citrinitas Capital, about the second-order effects of effective weight-loss drugs. He talks us through how he's evaluating the potential of the new meds and how he approaches possible 'mega-trends' like GLP-1 or AI.See omnystudio.com/listener for privacy information.
Released:
Aug 17, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 9: The 2016 Predictions Episode: Episode 9: The 2016 Predictions Episode by Odd Lots